Skip to content
CUSTOMER SUPPORT
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations

Year: 2022

Quarterly Activity Report – Clarification

Quarterly Activity Report and Appendix 4C for Q1 FY2023

2022 Annual Report

2022 Annual Report

FY22 Full Year Results

Appendix 4E – Preliminary Final Report

Amended Quarterly Activity Report and Appendix 4C – Q4 FY2022

Quarterly Activity Report and Appendix 4C for Q4 FY2022

Quarterly Activity Report and Appendix 4C for Q34 FY2022

4DMedical Reports 1H FY22 Results

Next →
Software Products
  • CAC™
  • CT LVAS™
  • LDAf™
  • LDAi™
  • RV/LV Analysis™
  • XV LVAS®
  • Lung Density Analysis™ – Inspiration
  • Lung Texture Analysis™
  • PHA™
  • IQ-UIP
Hardware Products
  • Permetium™
  • XV Scanner™
  • About
  • Careers
  • Clinical Research
  • Investor
  • News
  • Contact us
  • Intellectual Property
  • Product Regulatory Information
  • Scan Location

Locations

  • Level 7/700 Swanston Street Carlton VIC 3053 Australia +61 03 9545 5940
  • 21255 Burbank Blvd Suite 120Woodland Hills CA 91367 (Toll Free) 1 833 987 2267
  • ©4DMedical 2025
  • Terms of Use
  • Privacy Policy
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations
CUSTOMER SUPPORT